Bulletin
Investor Alert

New York Markets Close in:

Merit Medical Systems Inc.

NAS: MMSI

GO
/marketstate/country/us

Market open

 --Real time quotes

May 27, 2022, 2:51 p.m.

/zigman2/quotes/209183774/composite

$

62.24

Change

+1.45 +2.39%

Volume

Volume 99,504

Real time quotes

/zigman2/quotes/209183774/composite

Previous close

$ 60.79

$ 62.24

Change

+1.45 +2.39%

Day low

Day high

$61.26

$63.12

Open

52 week low

52 week high

$51.66

$73.85

Open

Company Description

Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. It operates through the Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and ...

Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. It operates through the Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups. The Endoscopy segment integrates non-vascular stent technology with balloon dilators, inflation devices, guide wires, procedure kits, and other devices that are used by gastroenterologists, endoscopists, pulmonologists, and thoracic and general surgeons. The company was founded by Fred P. Lampropoulos, Darla Gill, Kent W. Stanger, and William Padilla in July 1987 and is headquartered in South Jordan, UT.

Valuation

P/E Current

71.96

P/E Ratio (with extraordinary items)

72.80

P/E Ratio (without extraordinary items)

73.75

Price to Sales Ratio

3.31

Price to Book Ratio

3.39

Price to Cash Flow Ratio

22.38

Enterprise Value to EBITDA

20.67

Enterprise Value to Sales

3.34

Efficiency

Total Asset Turnover

0.65

Liquidity

Current Ratio

2.04

Quick Ratio

1.10

Cash Ratio

0.29

Profitability

Gross Margin

40.76

Operating Margin

7.67

Pretax Margin

4.99

Net Margin

4.49

Return on Assets

2.93

Return on Equity

4.85

Return on Total Capital

6.03

Capital Structure

Total Debt to Total Assets

19.11

Officers and Executives

Name Age Officer Since Title
Mr. Fred P. Lampropoulos 70 1987 Chairman, President & Chief Executive Officer
Mr. Neil Peterson - - Vice President-Operations
Mr. Raul Parra 42 2009 Vice President-Accounting
Mr. Joseph Pierce - 1991 Applications Director
Mr. Jason Treft - 2007 Chief Technology Officer

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
02/28/2022 Fred P. Lampropoulos
PRESIDENT AND CEO; Director
7,832   Derivative/Non-derivative trans. at $65.03 per share. 509,314
02/28/2022 Ronald A. Frost
CHIEF OPERATING OFFICER
1,942   Derivative/Non-derivative trans. at $65.03 per share. 126,288
02/28/2022 Joseph C. Wright
PRESIDENT, INTERNATIONAL
1,942   Derivative/Non-derivative trans. at $65.03 per share. 126,288
02/28/2022 Raul Parra
CFO AND TREASURER
1,942   Derivative/Non-derivative trans. at $65.03 per share. 126,288
02/28/2022 Brian Glen Lloyd
CHIEF LEGAL OFFICER, SECRETARY
1,942   Derivative/Non-derivative trans. at $65.03 per share. 126,288
02/26/2022 Fred P. Lampropoulos
PRESIDENT AND CEO; Director
17,680   Award at $0 per share. 0
02/26/2022 Ronald A. Frost
CHIEF OPERATING OFFICER
6,630   Award at $0 per share. 0
02/26/2022 Joseph C. Wright
PRESIDENT, INTERNATIONAL
6,630   Award at $0 per share. 0
02/26/2022 Raul Parra
CFO AND TREASURER
6,630   Award at $0 per share. 0
02/26/2022 Brian Glen Lloyd
CHIEF LEGAL OFFICER, SECRETARY
6,630   Award at $0 per share. 0
12/28/2021 Brian Glen Lloyd
CHIEF LEGAL OFFICER, SECRETARY
1,850   Gift at $0 per share. 0
09/15/2021 Joseph C. Wright
PRESIDENT, INTERNATIONAL
10,000   Disposition at $72.01 per share. 720,100
09/15/2021 Lynne N. Ward
Director
9,470   Disposition at $71.83 per share. 680,230
09/15/2021 Joseph C. Wright
PRESIDENT, INTERNATIONAL
10,000   Derivative/Non-derivative trans. at $17.27 per share. 172,700
09/15/2021 Lynne N. Ward
Director
14,867   Derivative/Non-derivative trans. at $34.46 per share. 512,316
09/10/2021 Jill D. Anderson
Director
850   Disposition at $71.64 per share. 60,894
09/09/2021 Raul Parra
CFO AND TREASURER
2,000   Disposition at $72 per share. 144,000
09/09/2021 Raul Parra
CFO AND TREASURER
2,000   Derivative/Non-derivative trans. at $44.8 per share. 89,600
09/08/2021 Fred P. Lampropoulos
PRESIDENT AND CEO; Director
2,410   Derivative/Non-derivative trans. at $72.23 per share. 174,074
09/08/2021 Raul Parra
CFO AND TREASURER
2,000   Disposition at $72.01 per share. 144,020
09/08/2021 Fred P. Lampropoulos
PRESIDENT AND CEO; Director
5,000   Derivative/Non-derivative trans. at $17.27 per share. 86,350
09/08/2021 Raul Parra
CFO AND TREASURER
2,000   Derivative/Non-derivative trans. at $44.8 per share. 89,600
06/17/2021 Aldon Scott Anderson
Director
2,914   Award at $0 per share. 0
06/17/2021 F. Ann Millner
Director
2,914   Award at $0 per share. 0
06/17/2021 Lynne N. Ward
Director
2,914   Award at $0 per share. 0
06/17/2021 James T. Hogan
Director
2,914   Award at $0 per share. 0
06/17/2021 David K. Floyd
Director
2,914   Award at $0 per share. 0
06/17/2021 Jill D. Anderson
Director
2,914   Award at $0 per share. 0
06/17/2021 Lonny J. Carpenter
Director
2,914   Award at $0 per share. 0
06/17/2021 Thomas J. Gunderson
Director
2,914   Award at $0 per share. 0
06/17/2021 Stephen C Evans
Director
2,914   Award at $0 per share. 0
06/15/2021 Ronald A. Frost
CHIEF OPERATING OFFICER
11,887   Disposition at $61.82 per share. 734,854
06/15/2021 Ronald A. Frost
CHIEF OPERATING OFFICER
20,000   Derivative/Non-derivative trans. at $17.27 per share. 345,400
05/25/2021 Raul Parra
CFO AND TREASURER
5,000   Disposition at $63.76 per share. 318,800
05/25/2021 Raul Parra
CFO AND TREASURER
4,000   Derivative/Non-derivative trans. at $28.2 per share. 112,800
05/25/2021 Raul Parra
CFO AND TREASURER
1,000   Derivative/Non-derivative trans. at $16.05 per share. 16,050
/news/latest/company/us/mmsi

MarketWatch News on MMSI

  1. Merit Medical Systems stock price target raised to $83 from $73 at Needham

    5:59 a.m. July 30, 2021

    - Tomi Kilgore

  2. Merit Medical Reaches Deal With Starboard Value

    9:30 p.m. May 29, 2020

    - Barron's Online

  3. Merit Medical Systems upgraded to outperform from market perform at Raymond James

    8:27 a.m. Feb. 3, 2020

    - Tomi Kilgore

  4. Activists Made Moves in Trinity Industries, B. Riley, Axonics

    2:24 p.m. Feb. 3, 2020

    - Barron's Online

  5. Merit Medical Systems started at outperform with $40 stock price target at Oppenheimer

    9:13 a.m. Sept. 24, 2019

    - Tomi Kilgore

  6. Funds’ Most Loved – and Hated – Small-Cap Stocks

    9:04 a.m. Sept. 17, 2019

    - Barron's Online

  7. Merit Medical Systems downgraded to market perform from outperform at Raymond James

    8:16 a.m. Sept. 10, 2019

    - Tomi Kilgore

  8. Merit Medical Systems stock price target raised to $68 vs. $62 at SunTrust

    7:25 a.m. Aug. 27, 2018

    - Ciara Linnane

  9. Merit Medical Systems price target raised to $59 from $51 at Raymond James

    7:58 a.m. May 22, 2018

    - Tonya Garcia

  10. Merit Medical Systems price target raised to $62 from $55 at SunTrust Robinson Humphrey

    8:05 a.m. May 18, 2018

    - Tonya Garcia

  11. These 55 stocks have at least doubled since Trump was elected

    4:04 p.m. Dec. 19, 2017

    - Philip van Doorn

  12. Evercore ISI Sees 20% Upside in Salesforce.com

    12:02 a.m. April 8, 2017

    - Barron's Online

  13. Home Depot Looks Fit, UPS Looks Squeezed

    1:25 a.m. Feb. 25, 2017

    - Barron's Online

  14. How to Play the Healthcare Rally

    1:37 p.m. April 1, 2015

    - Barrons Blogs

  15. Preview

    4:39 p.m. March 3, 2015

    - Barron's Online

  16. Monday’s biggest gaining and declining stocks

    2:33 p.m. April 16, 2012

    - MarketWatch

  17. Friday’s biggest gaining and declining stocks

    5:39 p.m. Feb. 24, 2012

    - Kate Gibson

  18. Preview

    1:01 p.m. May 2, 2011

    - Barron's Online

  19. American Public Education leads small-cap advance

    6:33 p.m. Feb. 18, 2011

    - MarketWatch

  20. Loading more headlines...
/news/nonmarketwatch/company/us/mmsi

Other News on MMSI

  1. Why Is Merit Medical (MMSI) Down 4.3% Since Last Earnings Report?

    12:09 p.m. Today

    - Zacks.com

  2. Merit Medical (MMSI) is a Top-Ranked Value Stock: Should You Buy?

    9:40 a.m. Today

    - Zacks.com

  3. 10-Q: MERIT MEDICAL SYSTEMS INC

    1:56 p.m. May 6, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  4. Merit Medical (MMSI) Q1 Earnings Beat, FY22 View Unchanged

    12:19 p.m. April 28, 2022

    - Zacks.com

  5. Merit Medical's (MMSI) SCOUT Bx Delivery System Gets FDA Nod

    10:39 a.m. April 12, 2022

    - Zacks.com

  6. Merit Medical gets FDA clearance for its SCOUT Bx Delivery System

    10:05 a.m. April 11, 2022

    - Seeking Alpha

  7. Tracking Jeff Smith's Starboard Value Portfolio - Q4 2021 Update

    10:43 p.m. March 29, 2022

    - Seeking Alpha

  8. Merit Medical gains on report of exploring potential sale

    2:03 p.m. March 9, 2022

    - Seeking Alpha

  9. Merit Medical's (MMSI) Product Included in FDA's Program

    10:03 a.m. March 8, 2022

    - Zacks.com

  10. Loading more headlines...

At a Glance

Merit Medical Systems, Inc.

1600 West Merit Parkway

South Jordan, Utah 84095

Phone

1 8012531600

Industry

Medical Equipment/Supplies

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2022

Revenue

$1.08B

Net Income

$48.45M

Employees

6,446

/news/pressrelease/company/us/mmsi

Press Releases on MMSI

  1. Merit Medical Reports Results for Quarter Ended March 31, 2022

    4:05 p.m. April 27, 2022

    - GlobeNewswire

  2. Merit Medical Announces Chief Operating Officer Transition

    4:05 p.m. April 21, 2022

    - GlobeNewswire

  3. Merit Medical Announces Launch of ReSolve(R) Thoracostomy Tray

    9:25 a.m. April 18, 2022

    - GlobeNewswire

  4. Loading more headlines...
Link to MarketWatch's Slice.